[{"NetIncomeLoss_1_Q3_USD":-90915.0,"Assets_0_Q3_USD":346471407.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_2_Q3_USD":-126762.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":329263730.0,"AdministrativeFeesExpense_2_Q3_USD":25000.0,"AssetsCurrent_0_Q3_USD":1380358.0,"NetCashProvidedByUsedInInvestingActivities_2_Q3_USD":-345000000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts_1_Q3_USD":-19543641.0,"AccruedLiabilitiesCurrent_0_Q3_USD":97367.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GeneralAndAdministrativeExpense_1_Q3_USD":157125.0,"GeneralAndAdministrativeExpense_2_Q3_USD":183829.0,"PreferredStockSharesOutstanding_0_Q3_shares":null,"Liabilities_0_Q3_USD":12207667.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1176843.0,"IncreaseDecreaseInAccountsPayable_2_Q3_USD":35300.0,"NetCashProvidedByUsedInFinancingActivities_2_Q3_USD":346524614.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q3_USD":8900000.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":345091049.0,"IncreaseDecreaseInAccruedLiabilities_2_Q3_USD":12367.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PrepaidExpenseCurrent_0_Q3_USD":203515.0,"PaymentsForRepurchaseOfPrivatePlacement_1_Q3_USD":8900000.0,"PreferredStockValue_0_Q3_USD":null,"NetIncomeLoss_2_Q3_USD":-117619.0,"PreferredStockSharesIssued_0_Q3_shares":null,"ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_2_Q3_USD":250000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q3_USD":1.0,"AdditionalPaidInCapital_0_Q3_USD":5116609.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_2_Q3_USD":16745.0,"AccountsPayableCurrent_0_Q3_USD":35300.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q3_USD":1176843.0,"LiabilitiesCurrent_0_Q3_USD":132667.0,"NetCashProvidedByUsedInOperatingActivities_2_Q3_USD":-347771.0,"IncomeLossFromEquityMethodInvestments_2_Q3_USD":91049.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-117619.0,"StockholdersEquity_0_Q3_USD":5000010.0,"ProfitLoss_1_Q3_USD":-90915.0,"OperatingExpenses_1_Q3_USD":181964.0,"OperatingExpenses_2_Q3_USD":208668.0,"ProceedsFromLoanOriginations1_2_Q3_USD":127000.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":346471407.0,"PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts_1_Q3_USD":345000000.0,"IncreaseDecreaseInPrepaidExpense_2_Q3_USD":203515.0,"Ticker":"RBOT","CIK":"1812173","name":"D8 HOLDINGS CORP.","OfficialName":"Vicarious Surgical Inc. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"529888564.0","Country":"Hong Kong","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20201113"}]